Inotiv News

Lake Street Maintains Inotiv(NOTV.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsSep 17 09:31 ET

Lake Street Maintains Inotiv(NOTV.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsSep 16 10:32 ET

Lake Street Sticks to Their Hold Rating for Inotiv (NOTV)

TipRanksSep 16 09:39 ET

Inotiv (NOTV) Gets a Hold From Lake Street

TipRanksAug 9 09:58 ET

Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating

Moomoo NewsAug 6 09:37 ET

Craig-Hallum Maintains Inotiv(NOTV.US) With Buy Rating

Moomoo NewsAug 5 09:31 ET

Inotiv (NOTV) Gets a Buy From Craig-Hallum

TipRanksAug 5 08:57 ET

Inotiv (NOTV) Gets a Buy From Craig-Hallum

TipRanksJul 19 09:29 ET

Inotiv Analyst Ratings

BenzingaMay 16 11:40 ET

Inotiv Analyst Ratings

BenzingaMay 14 08:18 ET

Jefferies Downgrades Inotiv to Hold From Buy, Price Target Is $3.75

MT NewswiresMay 14 07:24 ET

Inotiv (NOTV) Receives a Buy From Craig-Hallum

TipRanksMay 6 09:15 ET

Analysts Offer Insights on Healthcare Companies: Natera (NTRA) and Inotiv (NOTV)

TipRanksApr 8 09:06 ET

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)

TipRanksMar 26 08:55 ET

Craig-Hallum Keeps Their Buy Rating on Inotiv (NOTV)

TipRanksMar 25 10:31 ET

Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), BioLife Solutions (BLFS) and Inotiv (NOTV)

TipRanksMar 1 09:01 ET

Craig-Hallum Sticks to Its Buy Rating for Inotiv (NOTV)

TipRanksFeb 14 08:47 ET

Jefferies Upgrades Inotiv to Buy, Cites Expanded Sales Force

Seeking AlphaFeb 9 17:29 ET

Inotiv Analyst Ratings

BenzingaFeb 9 05:27 ET

Inotiv Upgraded to Buy With Target Raised to $11.50 From $3

InvestingFeb 9 04:34 ET